MetaCap

EyePoint Statistics

NASDAQ: EYPTIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

0.2342-0.03 (-11.36%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EyePoint by the numbers

EyePoint has a market capitalization of $26.6 million based on 113.78M shares outstanding. With trailing EPS of $-3.97, EyePoint is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 87.8% below its 50-day average and 97.6% below its 200-day average.

Average daily trading volume is 8.37M shares, or about $2.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EYPT valuation vs. peer median

EYPT compared with the median of 8 peer companies
MetricEYPTPeer medianDifference
Market cap$26.65M$34.24M-22%
Avg. volume8.37M396.66K+2011%

Peer median across 8 companies: PRPO, CIRC, RPID, HBIO, BNGO, ASTC, SEER, QTRX.

Valuation

Market cap
$26.65M
Price / sales (latest FY)
0.85
EPS (TTM)
$-3.97

Price and trading

Previous close
0.2642
Open
0.26
Day range
0.2277 – 0.265
52-week range
0.2277 – 19.11
52-week change
-98.29%
Beta
—
Volume
4.93M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
26.65M
Forward Pe
-0.14
Eps
-3.97
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
19.11
Week52 Low
0.23
Avg Volume
8.37M
Shares Outstanding
113.78M
Ma50
1.92
Ma200
9.91
Earnings Date
Nov 12, 2026
Pct From52w High
-98.77%
Pct From52w Low
2.85%

Related